Pay in 4 interest-free payments of $5.05 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
Mazdutides approval in China and advancing global development means more clinical experience exists with the compound in real-world settings
Early-phase clinical trial data, including results from a Phase 2 trial published in The New England Journal of Medicine in 2023, demonstrated substantial weight reductions in some participants exceeding 20% of body weight over 48 weeks alongside a broadly manageable short-term adverse effect profile
The risk climbs
Potential Long-Term Nutrition Risks In addition to short-term side effects, there are potential long-term nutrition risks to consider
US$ 25.64
US$ 20.99
US$ 25.74
